Globe News Wire

02 Jun 2026, 06:30 UTC · 2h ago

Nanobiotix rejoint l'indice Euronext Tech Leaders

Read original · https://www.globenewswire.com/news-release/2026/06/02/3304858/0/fr/nanobiotix-rejoint-l-indice-euronext-tech-leaders.html

Search tags

Story key points

1 claims · impact-rated

What matters in this story

1
Nanobiotix has been admitted into the Euronext Tech Leaders segment and index. — Index inclusion typically increases institutional visibility and can drive passive fund inflows, which is positive for the stock's liquidity and price.
+0.30

Ticker attribution

Model heads

Sentiment in this article

NANO+0.80
The company has been admitted into the Euronext Tech Leaders index, increasing its visibility and attractiveness to international investors.

Relationships in this article

No ticker relationship head found.

Early access

You’re reading about it. Someone else is already positioned.

News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.

NANO

Browse live screenings

Impact vectors

3 dimensions · 9 clusters

6 related stories

GlobeNewsWire
2h ago
Nanobiotix Joins the Euronext Tech Leaders Index
- biotechnology
- cancer treatment
- euronext
Read

Nanobiotix rejoint l'indice Euronext Tech Leaders | News Impact Scree… · News Impact Screener

Nanobiotix rejoint l'indice Euronext Tech Leaders

What matters in this story

Sentiment in this article

Relationships in this article

You’re reading about it. Someone else is already positioned.

Nanobiotix Joins the Euronext Tech Leaders Index

Nanobiotix rejoint l'indice Euronext Tech Leaders

What matters in this story

Sentiment in this article

Relationships in this article

You’re reading about it. Someone else is already positioned.

Nanobiotix Joins the Euronext Tech Leaders Index

Analytical profile by cluster

Top impact dimensions

Most positively impacted

Most negatively impacted

European Gas Prices Fall But Winter Supply Risks Loom

Inventiva annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris

FDA Accepts New Drug Application for Genentech's Giredestrant in ER-Positive Early-Stage Breast Cancer, the First and Only Oral SERD With Positive Phase III Results in the Curative Setting

Iovance Stock Has Been Hammered. Is This the Buying Opportunity Aggressive Investors Have Been Waiting For?

Genomics Launches the Mystra AI Platform, Adopted by Industry Giants and Up-and-Coming Biotechs

Nanobiotix rejoint l'indice Euronext Tech Leaders

What matters in this story

Sentiment in this article

Relationships in this article

You’re reading about it. Someone else is already positioned.

Next reads from the same story arc

Nanobiotix Joins the Euronext Tech Leaders Index

Nanobiotix rejoint l'indice Euronext Tech Leaders

What matters in this story

Sentiment in this article

Relationships in this article

You’re reading about it. Someone else is already positioned.

Next reads from the same story arc

Nanobiotix Joins the Euronext Tech Leaders Index

Analytical profile by cluster

Top impact dimensions

Most positively impacted

Most negatively impacted

European Gas Prices Fall But Winter Supply Risks Loom

Inventiva annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris

FDA Accepts New Drug Application for Genentech's Giredestrant in ER-Positive Early-Stage Breast Cancer, the First and Only Oral SERD With Positive Phase III Results in the Curative Setting

Iovance Stock Has Been Hammered. Is This the Buying Opportunity Aggressive Investors Have Been Waiting For?

Genomics Launches the Mystra AI Platform, Adopted by Industry Giants and Up-and-Coming Biotechs